Login / Signup

A homologue of the Parkinson's disease-associated protein LRRK2 undergoes a monomer-dimer transition during GTP turnover.

Egon DeyaertLina WautersGiambattista GuaitoliAlbert KonijnenbergMargaux LeemansSusanne TerheydenArsen PetrovicRodrigo U GallardoLaura M Nederveen-SchippersPanagiotis S AthanasopoulosHenderikus PotsPeter J M Van HaastertFrank SobottChristian Johannes GloecknerRouslan EfremovArjan KortholtWim Versées
Published in: Nature communications (2017)
Mutations in LRRK2 are a common cause of genetic Parkinson's disease (PD). LRRK2 is a multi-domain Roco protein, harbouring kinase and GTPase activity. In analogy with a bacterial homologue, LRRK2 was proposed to act as a GTPase activated by dimerization (GAD), while recent reports suggest LRRK2 to exist under a monomeric and dimeric form in vivo. It is however unknown how LRRK2 oligomerization is regulated. Here, we show that oligomerization of a homologous bacterial Roco protein depends on the nucleotide load. The protein is mainly dimeric in the nucleotide-free and GDP-bound states, while it forms monomers upon GTP binding, leading to a monomer-dimer cycle during GTP hydrolysis. An analogue of a PD-associated mutation stabilizes the dimer and decreases the GTPase activity. This work thus provides insights into the conformational cycle of Roco proteins and suggests a link between oligomerization and disease-associated mutations in LRRK2.
Keyphrases
  • protein protein
  • amino acid
  • molecular dynamics
  • emergency department
  • genome wide
  • dna methylation
  • mass spectrometry
  • dna repair
  • bone mineral density
  • adverse drug
  • dna binding
  • tandem mass spectrometry